Furafylline
Jump to navigation
Jump to search
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C12H12N4O3 |
Molar mass | 260.253 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Furafylline is a methylxanthine derivative that was introduced in hope of being a long-acting replacement for theophylline in the treatment of asthma.[1] It is an inhibitor of CYP1A2.[1]
References
- ^ a b Sesardic D, Boobis AR, Murray BP, Murray S, Segura J, de la Torre R, Davies DS (June 1990). "Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man". British Journal of Clinical Pharmacology. 29 (6): 651–63. doi:10.1111/j.1365-2125.1990.tb03686.x. PMC 1380167. PMID 2378786.
Categories:
- Articles with short description
- Short description matches Wikidata
- Drugs not assigned an ATC code
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- Articles with changed InChI identifier
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- 2-Furyl compounds
- CYP1A2 inhibitors
- Phosphodiesterase inhibitors
- Xanthines
- All stub articles
- Respiratory system drug stubs